Graves Ophthalmopathy Clinical Trials
2 recruiting trials for Graves Ophthalmopathy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Graves Ophthalmopathy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Sun Yat-sen University (1), Elazıg Fethi Sekin Sehir Hastanesi (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is modified deep lateral and/or medial wall decompression (procedure, 1 trial).
Track Graves Ophthalmopathy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.
Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease
This retrospective observational study aims to evaluate the relationship between systemic inflammatory parameters, thyroid autoimmunity markers, and neuroretinal structures in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Graves Ophthalmopathy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Graves Ophthalmopathy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Graves Ophthalmopathy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.